Drug Pipeline

Ripretinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07618377 Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03673501 A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Gastrointestinal Stromal Tumors Active, Not Recruiting
Phase 1/2
NCT05957367 A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in… GIST Recruiting
Phase 1
NCT07618377 Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments Gastrointestinal Stromal Tumors Not Yet Recruiting
Sponsors Running Ripretinib Trials
Deciphera Pharmaceuticals, LLC (2) Ono Pharmaceutical Co., Ltd. (1)
Get alerts when Ripretinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free